NBTXR3 Activity in Soft Tissue Sarcoma Could Be Replicated in Other Cancers
OncLive,
NBTXR3, a novel radioenhancer, is showing intriguing response rates in adult patient with soft tissue sarcoma, paving a path…
NBTXR3, a novel radioenhancer, is showing intriguing response rates in adult patient with soft tissue sarcoma, paving a path…
Radiotherapy is used in 60% of cancer cases, but it is prone to damaging nearby healthy cells and can be ineffective against…